The Journal of Allergy and Clinical Immunology
Volume 125, Issue 3 , Pages 711-718.e2, March 2010

Naturally processed T cell–activating peptides of the major birch pollen allergen

  • Sonja Mutschlechner, PhD

      Affiliations

    • Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria
    • Christian Doppler Laboratory for Immunomodulation, Department of Pathophysiology, Center of Physiology, Pathophysiology and Immunology, Medical University of Vienna, Vienna, Austria
  • ,
  • Matthias Egger, PhD

      Affiliations

    • Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria
  • ,
  • Peter Briza, PhD

      Affiliations

    • Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria
  • ,
  • Michael Wallner, PhD

      Affiliations

    • Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria
  • ,
  • Peter Lackner, PhD

      Affiliations

    • Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria
  • ,
  • Anette Karle, PhD

      Affiliations

    • F. Hoffmann-La Roche Ltd, Immunosafety, Non-Clinical Safety, Basel, Switzerland
  • ,
  • Anne B. Vogt, PhD

      Affiliations

    • F. Hoffmann-La Roche Ltd, Immunosafety, Non-Clinical Safety, Basel, Switzerland
  • ,
  • Gottfried F. Fischer, MD

      Affiliations

    • Clinical Department for Blood Group Serology, University Clinic for Blood Group Serology and Transfusion Medicine, Vienna, Austria
  • ,
  • Barbara Bohle, PhD

      Affiliations

    • Christian Doppler Laboratory for Immunomodulation, Department of Pathophysiology, Center of Physiology, Pathophysiology and Immunology, Medical University of Vienna, Vienna, Austria
    • Corresponding Author InformationReprint requests: Barbara Bohle, PhD, Institute of Pathophysiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
    • These authors are cosenior authors of this article.
  • ,
  • Fatima Ferreira, PhD

      Affiliations

    • Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria
    • Corresponding Author InformationFatima Ferreira, PhD, Department of Molecular Biology, University of Salzburg, Hellbrunner Strasse 34, 5020 Salzburg, Austria.
    • These authors are cosenior authors of this article.

Received 10 July 2009; received in revised form 6 October 2009; accepted 29 October 2009. published online 04 February 2010.

Background

Although antigen processing and presentation of allergens to CD4+T lymphocytes are key events in the pathophysiology of allergic disorders, they still remain poorly understood.

Objective

To investigate allergen processing and presentation by dendritic cells using the major birch pollen allergen Bet v 1 as a model.

Methods

Endolysosomal extracts of dendritic cells derived from patients with birch pollen allergy were used to digest Bet v 1. Dendritic cells were pulsed with Bet v 1, and peptides were eluted from MHC class II molecules. Peptides obtained by either approach were sequenced by tandem mass spectrometry. Bet v 1–specific T-cell cultures were stimulated with HLA-DR–eluted Bet v 1–derived peptides. Bet v 1–specific T-cell lines were generated from each patient and analyzed for epitope recognition.

Results

A high proportion of Bet v 1 remained intact for a long period of endolysosomal degradation. The peptides that appeared early in the degradation process contained frequently recognized T-cell epitopes. Bet v 1–derived peptides eluted from MHC class II molecules corresponded to those generated by endolysosomal degradation, matched known T-cell epitopes, and showed T cell–activating capacity. The Bet v 1–specific T-cell line of each individual harbored T cells reactive with peptides located within the MHC class II–eluted Bet v 1–derived sequences demonstrating their occurrence in vivo.

Conclusion

We report for the first time how epitopes of allergens are generated and selected for presentation to T lymphocytes. The limited susceptibility of Bet v 1 to endolysosomal processing might contribute to its high allergenic potential.

Key words: Birch pollen allergy, Bet v 1, antigen processing, antigen presentation, dendritic cells, T cells, T-cell epitopes

Abbreviations used: aa, Amino acid, APC, Antigen-presenting cell, cpm, Counts per minute, DC, Dendritic cell, SI, Stimulation index, TCC, T-cell clone, TCL, T-cell line

 

 Supported by P10150 of the Österreichische Nationalbank, the Christian Doppler Laboratory for Allergy Diagnosis and Therapy, and the Christian Doppler Laboratory for Immunomodulation, Austria.

 Disclosure of potential conflict of interest: F. Ferreira has received research support from Biomay AG, the Austrian Science Fund, the Christian Doppler Research Association, and the Austrian National Bank and has provided legal consultation services or expert witness testimony relevant to Indoor Biotechnologies and AllergenOnline Database. B. Bohle has received research support from the Austrian Science Fund and the Christian Doppler Laboratory. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(09)01629-7

doi:10.1016/j.jaci.2009.10.052

The Journal of Allergy and Clinical Immunology
Volume 125, Issue 3 , Pages 711-718.e2, March 2010